CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Report for D002032: Bulimia NIH

(Synonyms: Bulimia)

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug637 Control (albumin 5%) Wiki 1.00
drug649 Convalescent Plasma (anti-SARS-CoV-2 plasma) Wiki 0.71

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D001068 Feeding and Eating Disorders NIH 0.50

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0100739 Bulimia HPO 1.00

There is one clinical trial.

Clinical Trials


1 Biological Risk Factors for Onset of Binge Eating and Compensatory Behaviors

The purpose of this proposed project is to test whether several biological factors (such as elevated brain reward region and attention region response to high-calorie foods, weaker inhibitory region response to high-calorie foods, habitual caloric deprivation, and elevated limbic region responsivity) increase the risk of problematic eating (bingeing and purging) in female adolescents.

NCT03687346 Eating Disorder
MeSH:Bulimia Feeding and Eating Disorders
HPO:Bulimia

Primary Outcomes

Description: Eating Disorder Diagnostic Interview (EDDI)

Measure: Change in binge eating behaviors using the EDDI

Time: 6 months, 1 year, 2 year, and 3 year follow-up

Description: Eating Disorder Diagnostic Interview (EDDI)

Measure: Change in compensatory behaviors using the EDDI

Time: 6 months, 1 year, 2 year, and 3 year follow-up


HPO Nodes


Protein Mutations 1
V158M
SNP 0